Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

New P2Y1 antagonist will facilitate further study of the receptor and its physiological role

May 21, 1998

No Comments

Lilly initiates pivotal trials with SkyePharma formulation

May 20, 1998

No Comments

Phytera signs R&D and marketing agreement with NeuroSearch

May 19, 1998

No Comments

Biovector licenses DNA delivery technology from NIH

May 19, 1998

No Comments

CombiChem achieves milestone in Roche Bioscience collaboration

May 18, 1998

No Comments

Phytera and Galileo enter into collaborative agreement

May 18, 1998

No Comments

Andaris granted U.S. patent for microcapsule technology

May 15, 1998

No Comments

CombiChem achieves milestone in collaboration with Teijin

May 14, 1998

No Comments

VP22 provides intercellular delivery of functional p53 protein

May 14, 1998

No Comments

Evotec awarded German grant for drug discovery

May 13, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

New P2Y1 antagonist will facilitate further study of the receptor and its physiological role

Lilly initiates pivotal trials with SkyePharma formulation

Phytera signs R&D and marketing agreement with NeuroSearch

Biovector licenses DNA delivery technology from NIH

CombiChem achieves milestone in Roche Bioscience collaboration

Phytera and Galileo enter into collaborative agreement

Andaris granted U.S. patent for microcapsule technology

CombiChem achieves milestone in collaboration with Teijin

VP22 provides intercellular delivery of functional p53 protein

Evotec awarded German grant for drug discovery

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS